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Abstract 
 
Background. Homeless individuals are at high risk of contracting the Hepatitis C virus 
(HCV) given that many use intravenous drugs or have a prison history, common risk factors for 
the disease. Although there is no vaccine, it is curable.  
Methods. This cross-sectional study surveyed residents (n=120) of five homeless shelters 
in Connecticut to understand their screening willingness and knowledge about HCV.  
Results. Those who tested previously (OR=0.46, 95% CI 0.23-0.90) and those who had 
never spent time in prison (OR=0.39, 95% CI 0.15-0.98) were less willing to be screened. Most 
did not recognize HCV symptoms and risk factors. 
Conclusions. The study revealed that 12.5% of those surveyed have HCV and 60% had 
been to prison. Although 67.8% indicated HCV knowledge, the mean grade on the quiz was 
48.6%.  
Discussion. 92.5% had been to a doctor within the past year, yet HCV and screening do 
not appear to have been discussed. 
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Foundational and Concentration Competencies 
This thesis addressed the following foundational and concentration competencies 
required for the Master of Public Health Sciences program.  The table below outlines the specific 
competencies and how they were fulfilled. 
Foundational Competency How Addressed in the Thesis 
2. Select quantitative and qualitative data 
collection methods appropriate for a given 
public health context  
A self-administered original survey was the 
primary means of data collection. The 28-
question survey included both quantitative 
and qualitative data. 
3. Analyze quantitative and qualitative data 
using biostatistics, informatics, computer-
based programming and software, as 
appropriate 
The researcher leveraged the statistical 
software SAS v. 9.4 to analyze the survey 
results, which were both quantitative and 
qualitative. 
4. Interpret results of data analysis for public 
health research, policy or practice 
The results of the data analysis provided 
opportunities for not only additional public 
health research but also changes to policies of 
screening for Hepatitis C and the practice of 
educating the homeless population during 
provider visits.  
7. Assess population needs, assets and 
capacities that affect communities’ health 
This survey assessed the needs for screening 
locations and knowledge of Hepatitis C 
among those experiencing homelessness that 
if improved, could impact this public health 
concern. 
9. Design a population-based policy, program, 
project or intervention 
The thesis analysis provides the data and 
groundwork to propose a population-based 
policy, program, or intervention to better 
educate this population as to their risks of the 
disease, as well as the opportunity to create 
more screening programs and insurance 
coverage for treatment. 
19. Communicate audience-appropriate public 
health content, both in writing and through 
oral presentation 
The e-poster and supporting content provides 
an example of communicating the research 
and health content to a broad audience. 
22. Apply systems thinking tools to a public 
health issue 
Leveraged a holistic approach to understand 
the issue, the contributing factors, and 
proposed next steps that require a multi-
faceted approach to address the problem.  
This thesis explored a multitude of 
components and sought to address the issue 
by exploring the ‘system’ of homelessness. 
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Systems Thinking 
This thesis applied a systems thinking framework by taking a holistic approach to the 
public health concern that people experiencing homelessness are more likely to have Hepatitis C.  
This study employed the disciplined approach to understand the problem of what prevents or 
inhibits this vulnerable population from seeking screening tests by exploring a variety of factors 
that contribute to the ‘system’ of homelessness and understanding which variables may affect 
other factors. This thesis leveraged a 28-question survey to better understand if any patterns or 
trends existed which would help identify any underlying structures or predictors that drove those 
trends. The goal was to view a broader perspective of the situation before proposing any 
recommendations. By understanding the situation more fully, the researcher was able to ask 
richer questions when crafting possible solutions. The ability to recognize the inter-related 
components, such as the various demographic characteristics and the homeless duration and 
experiences, combined with access to healthcare, prison history, and past testing experience, 
provided a broader view of the challenges faced by this population.  This research identified 
inter-related components that must be addressed in order to create a viable, long-term solution. 
Hepatitis C is a chronic, deadly disease and an important public health concern. The goal 
of leveraging a systems thinking approach is to discover new ways of thinking about this 
problem and ultimately to propose solutions that will identify new ways to think about the 
various factors that contribute to homelessness and a person’s willingness to be screened.  The 
goal of taking a systems approach is to find creative solutions that will improve not only the 
education of the risks and transmission of this disease, but to increase screening tools to deepen 
the understanding of the prevalence and need for treatment in this vulnerable population. 
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Background 
Hepatitis C is a chronic blood-borne liver infection caused by the Hepatitis C virus 
(HCV), and according to the World Health Organization (WHO), more than 71 million people 
worldwide affected (WHO, 2016).  Since its discovery in 1989, HCV has become recognized as 
the leading cause of chronic liver disease globally (Aisyah et al., 2018), which can culminate in 
liver failure and death.  In order to eliminate this public health threat, the WHO has identified a 
target date of 2030 to accomplish this task.  In the United States, it is estimated that 
approximately 2.4 million people have the disease, according to the most recent data by the 
Centers for Disease Control and Prevention (CDC) (Hofmeister et al, 2019). This count is likely 
a significant underestimate, as the marginalized populations that are prone to experience high 
prevalence of the disease, namely those experiencing homelessness and prison populations, are 
often not included in surveys.  The true burden of this disease is not fully known without 
inclusion of the data from these populations. Several studies estimate that the prevalence of HCV 
in the homeless populations in the United States ranges between 3% and 75% (Hofmeister at al., 
2019; Jain et al., 2019; Page et al., 2017), although these estimates vary by age.  
Intravenous drug use is the most common risk factor of Hepatitis C in developed 
countries, particularly when users share needles or other injection equipment (Read et al., 2017). 
People in prisons or other enclosed environments, those who have received transfusions of 
unscreened blood, people with sexual partners who have HCV, or people with piercings and 
tattoos are also highly vulnerable (WHO, 2016).  Although there is no vaccine for Hepatitis C, 
the disease is curable via direct acting antivirals (DAAs).  The treatments have changed over 
time and are now much more effective and have fewer side-effects than the previous interferon-
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containing regimens.  Both screening methods and treatments have improved over the past few 
years, and the treatment guidelines continue to be updated to reflect the latest practices.   
Hepatitis C can cause both acute and chronic hepatitis and is the leading cause of liver 
cancer. Although a small number of cases spontaneously clear without any intervention, between 
70% and 85% of cases become chronic conditions that can be life-threatening without medical 
intervention (CDC, 2019).  Early detection and treatment are essential in preventing the spread of 
this contagious virus.  Moreover, ensuring access to Hepatitis C screening and treatment among 
intravenous drug users, many of whom are homeless, could substantially reduce HCV 
transmission and have significant public health benefits. 
The goal of this descriptive study is two-fold.  This study first explores how much those 
experiencing homelessness know about Hepatitis C and secondly examines which factors are 
associated with the willingness of a person experiencing homelessness to be screened for 
Hepatitis C.  The research helps identify whether age, gender, race, ethnicity, education, history 
and duration of homelessness, location of screening test, and awareness of health risks of 
Hepatitis C are associated with a disposition to be screened for HCV.   
Literature Review 
This section describes the similarities and differences in the existing literature and 
research on the screening and treatment of Hepatitis C among the homeless population. Since 
both homelessness and Hepatitis C are global issues, many of the articles describe research in 
other parts of the world including Europe, Australia, the Middle East, and Canada.  The 
generalizability of these findings to all the homeless is unclear, as more research would need to 
be conducted to understand populations in different regions of the US and other countries. Even 
within the United States there may be differences among those experiencing homelessness amid 
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the different geographic areas that would warrant further investigation (Aisyah et al, 2018; Read 
et al 2017).   
In the review of literature on homelessness and Hepatitis C screening and treatment, there 
are many consistent findings. Nearly all the studies conclude that people experiencing 
homelessness are disproportionately affected not only by drug use, but also by their ability to 
access healthcare, because this vulnerable population experiences high rates of social and racial 
inequities (Aisyah et al., 2018; Fuster & Gelberg, 2019). The literature consistently finds that 
being homeless limits the ability to receive medical care for HCV (Fuster & Gelberg, 2019). A 
few of the studies conclude that there are often coinfections with human immune-deficiency 
virus (HIV) and/or Hepatitis B virus (HBV) (Fuster & Gelberg, 2019; Page et al., 2017) among 
the homeless.   
Most researchers indicate that it is difficult, for many logistic considerations, to study 
people who inject drugs (PWID) among the homeless in order to accurately assess the prevalence 
of HCV (Fuster & Gelberg, 2019), and more epidemiological research may be needed to fully 
understand the HCV burden among these and other marginalized populations in the U.S.  This 
literature review demonstrates a consensus that the most common risk factors among the 
homeless for HCV are drug use and imprisonment (Aisyah et al., 2018; Brown et al., 2019). 
People experiencing homelessness often cite active drug use, fear of side effects, being in prison, 
or forgetfulness of the appointment as reasons why they do not attend screening and/or treatment 
clinics (Lambert et al., 2019). There is also unanimity in the finding that people experiencing 
homelessness have high emergency room utilizations and are less likely than their housed 
counterparts to seek regular primary care (Fuster & Gelberg, 2019).  
  
4 
 
Gaps in the Literature 
Most of the research on homelessness focuses on men, which is representative of the 
majority of the homeless population.  According to the U. S. Department of Housing and Urban 
Development, nearly 553,000 people experienced homelessness in the United States in 2018, and 
more than 70% of those were men (U.S. Department of Housing and Urban Development, 2018).  
While men comprise most of this population, only a handful of studies research HCV among 
women and youth, with youth defined as those aged 18 to 24 years of age.  These studies identify 
potentially unique needs for both screening and targeted treatment strategies for youth and 
women (Page et al., 2017).  
Research also identifies the most vulnerable population for HCV to be those born from 
1945 to 1965, also known as the ‘baby boomers’ (Jain et al., 2019). One study also claims that 
this population, in general, is five times more likely to be infected with HCV than their younger 
counterparts (Jain et al., 2019). While this demographic may still be of high concern for Hepatitis 
C, the advent of the opioid crisis has created a new potential concern for the younger population 
as well.  There is scant research that focuses on this newer generation and the challenges with 
PWID resulting from the use of opioids.   
To our knowledge, no research has addressed the willingness of the homeless to undergo 
screening, which, therefore, is the primary aim of the study.  Additionally, this study aims to 
learn if knowledge of Hepatitis C, and its risk factors, among the homeless population is related 
to their willingness to be screened.  Lastly, we will examine if knowledge and willingness are 
greater among baby boomers as compared to younger persons in the shelters.  We aim to 
evaluate whether or not baby boomers might have a greater understanding of issues related to 
Hepatitis C compared to the younger population.   
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Methods 
Study Design and Sample 
 This investigation is an observational cross-sectional study of homeless persons (n=120) 
ages 18-71 residing in five shelters in Hartford, New London, New Haven, and Waterbury, in 
which an anonymous self- administered survey was given that measured several factors to 
determine the level of awareness of the homeless population about Hepatitis C as well as their 
willingness to be screened, as described in more detail below. Shelters were selected based on 
the following criteria: county location in order to achieve statewide representation; and age and 
sex composition (men only, co-ed, youth). Several additional shelters across the state were 
contacted to participate in the study but did respond in time to participate despite follow-up 
emails and phone calls.  Many of the shelters are operating with a minimal staff and are 
extremely busy and simply missed the invitations.  Several shelter directors indicated to the 
researcher afterwards that they would have participated had they seen the emails or received the 
phone calls, and that they were very interested in participating in any future research.  The goal 
was to have at least one shelter in each of the seven Coordinated Access Network (CAN) in the 
state, yet the researcher was able to obtain representation from four of the CANs, as two shelters 
were located in New Haven. Due to time constraints, no further adjustments were made to gain 
representation from each CAN in this study. 
The study participants consisted of 82 homeless men (68.3%), 37 women (30.8%) and 
one transgender person. Of this population, 10 were classified as youth defined by the Housing 
and Urban Development (HUD) between the ages of 18 and 24 (HUD, 2018).   Only 5% (n=6) of 
the respondents requested Spanish surveys, with 95% of majority (n=114) requesting English 
surveys.  
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Nearly 30% of shelter residents in the past year in CT were Hispanic (of any race), half of 
the population White (47.9%), and 40% Black (40.3%) (CTHMIS, 2020).  The majority of 
shelter residents are aged 25 54 (56%), with both youth (7.1%) and clients over 62 (5.9%) having 
a much smaller representation (CTHMIS, 2020).   Data on the unsheltered population is not 
possible to define with accuracy, as they are not often known to the statewide agencies and 
providers who assist the homeless and are therefore not accurately represented in the state of 
Connecticut’s homeless management information system (HMIS). 
Inclusion/Exclusion Criteria 
The sampling frame consisted of shelters in Connecticut, and we sought to obtain a 
representative sample by including a location in multiple counties. Within each shelter, however, 
data were collected from a convenience sample of residents, i.e., those willing to take the survey 
during a single visit at the location. We included persons 18 years and older because children are 
not likely to have awareness of Hepatitis C nor opinions about treatment or screening. 
Unsheltered homeless were not part of the sampling frame primarily due to the challenges with 
finding them in the desired timeframe to complete the research.  The unsheltered are often found 
under bridges, in encampments, or in other areas not fit for human habitation Exclusion criteria 
included those who appeared to not have cognitive competence in addition to submitted surveys 
that were massively incomplete.  
Survey Distribution and Content 
The study was approved by the UCONN Health Institutional Review Board (IRB) with 
written approval from each shelter and anonymity of participants as conditions of approval.   
Based on the suggestion of each shelter, the researcher arrived usually around 5pm or 6pm for 
dinner service to capture the largest potential population or 6:30am for the breakfast service as 
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preferred at one shelter.  The researcher asked each participant if they were willing to take the 
survey, reiterated that it was optional and that any question could be skipped before handing over 
the paper survey and a pen.  Depending upon the shelter layout, the researcher either left the box 
unattended for two hours while remaining at the shelter or stood near the box while the 
participants completed the survey and directed them to put it in the box once completed.  In two 
shelters the shelter staff assisted in administering the surveys.  The survey was voluntary, 
administered anonymously, and was originally estimated to take no more than 10 minutes to 
complete; however, most respondents took about 20 minutes to complete the survey.   
The 28-question survey (Appendix A) consisted of three main sections: 1) demographics, 
2) Hepatitis C risk and knowledge, and 3) likelihood to get screened in various locations 
(hospital, community health clinic, shelter).  The demographic questions included age, gender, 
race, ethnicity, highest level of education completed, the date the respondent arrived at the 
shelter, and how long the respondent has been homeless. The questions relating to risks and 
knowledge about Hepatitis C included whether the person knows what Hepatitis C is, if he/she 
has ever been tested for Hepatitis C, and whether they have Hepatitis C. The survey included a 
ten-question ‘quiz’ regarding facts about transmission, symptoms, and treatment to which 
respondents indicated either True, False, or Unsure to convey their understanding of the virus. 
The final section of the survey asked questions about the likelihood of the respondent to 
attend a Hepatitis C screening at various locations, in addition to their intention to get treatment 
if the screening tested positive, as well as their desire to get help to stop substance use, if 
applicable.   
There was no compensation or incentive provided to complete the anonymous survey.   
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Privacy and Confidentiality 
The survey did not contain any sensitive questions that would warrant the need for 
privacy measures; given the locations in which these surveys were completed, it would have 
been difficult to ensure a completely private area to take the survey.  The researcher was the only 
person with access to the completed surveys and was the only person entering and storing the 
data.  There was no personally identifiable information captured on the survey.  There was a 
single health-protected information question pertaining to whether or not the person had 
Hepatitis C, and the researcher obtained prior Health Insurance Portability and Accountability 
Act (HIPAA) approval during the IRB process. 
Adequate Consent Procedures 
 The survey included a paragraph that stated the purpose and goals of the procedure, as 
well as a brief description of the research question being studied.  Moreover, the privacy and 
confidentiality details were clearly outlined and indicate that participation was completely 
voluntary.   
Data Analysis  
Descriptive statistical analyses included Chi-square tests to evaluate associations between 
categorical variables, and calculation of correlation coefficients between continuous variables. 
Logistic regression was performed to identify which independent variables (e.g., age, sex, 
knowledge of Hepatitis C), predicted whether or not they would be willing to undergo screening 
for Hepatitis C as measured by a dichotomous level (yes, no).  Odds ratios were used to assess 
magnitude of the associations. 
The questions regarding the participant’s willingness to go to various locations to be 
screened, originally asked using a 5-point Likert scale, were each converted into a binary 
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variable.  The responses of ‘5 – Very Likely’ and ‘4-Somewhat Likely’ were converted into a 
binary variable ‘Yes’.  The response ‘1 – Not at all likely’ and ‘2 – Somewhat unlikely’ were 
converted to a ‘No’ response.  The ‘3’ values were excluded as they were neutral values. The 
ages of the participants were grouped into four categories for the analysis:  18 to 24, 25 to 30, 31 
to 50, and over 51 years.  For the Chi square analysis, however, the age grouping of 18 to 24 
were grouped with 25 to 30 in order to meet the small cell size requirement. Likewise, the 
education levels were grouped into four categories: completed college, completed some college, 
completed high school or general education diploma (GED), and completed 11th grade or lower.  
The quiz scores were calculated on a 10-point scale, with one point for each correct answer.  
The dependent variable (i.e., willingness of a person experiencing homelessness to be 
screened for HCV)  was operationalized by asking participants the likelihood that they will get 
screened at a hospital, a local health clinic, or at their local shelter using a 5-point Likert scale 
ranging from 1 (not at all likely) to 5 (very likely).  The independent variables included age, 
gender, race, ethnicity, previous prison history, duration of homelessness, highest education level 
completed, whether they knew about Hepatitis C, if they had ever been tested for it, if they had 
Hepatitis C, and awareness of the health risks of Hepatitis C.    
Since the dependent or outcome variable is binary (‘Yes’ or ‘No’ as to whether the 
person experiencing homelessness is willing to get screened for Hepatitis C), and given that the 
independent variables are both continuous and categorical, a binary logistic regression analysis 
was the appropriate analytic method to predict the odds of being a case.  Binary logistic 
regression has several assumptions that must be met, including that the observations are 
independent of each other, that there is little or no multicollinearity among the independent 
variables, and linearity of the independent variables and log odds.   
  
10 
 
The data analysis for this paper was generated using SAS software. Copyright © 2016 
SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered 
trademarks or trademarks of SAS Institute Inc., Cary, NC, USA. 
Number of Variables per Participant 
We attempted to follow recommendations that there be at least 10 cases per predictor 
variable in a multivariate analysis (Green, 1991).  Since there were fourteen possible predictor 
variables, this study strived to attain a minimum of 140 participants. Ultimately, however, we 
included a maximum of six variables in the largest model analyzed. Given the lower than 
expected shelter response rate (n=5), combined with the three surveys that were rejected due to 
language challenges, the final usable number of surveys was 120.  Reasons for rejection (n=3): 
no questions were completed; only a few questions answered but with multiple answers selected 
for each question; and a survey from a woman who verbally struggled to understand the 
questions, including age and gender. 
Results 
As presented in Table 1, the mean age was 43.9 (SD=13.5), the median age was 43.5, and 
the mode age was 43.0 years representing a normal distribution.  This study revealed a point 
prevalence of Hepatitis C among this sample population of 12.5% (n=15), although the general 
population prevalence is estimated to be only 1% (CDC, 2020).  
  Forty-six percent of those taking the survey identified as White/Caucasian (n=80), while 
26% (n=30) identified as Black.  Two survey respondents identified their race as ‘Puerto Rican’ 
although this was not an option on the survey, and 5 individuals did not identify any race.  Three 
shelters had more white respondents than black, one shelter had more black than white, and one 
shelter had an equal amount of black and white clients.   
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      Nearly three quarters (n=80) indicated their ethnicity is non-Hispanic/non-Latino with the 
remaining 25% (n=28) claiming to be Hispanic or Latino.  
More than half (n=62) of those screened reported that they had been to prison. This actual 
number, however, is likely to be higher as several participants may not have wished to reveal this 
on the survey. 
Table 1. Demographic Characteristics of Study Sample 
Demographic n (%) 
Age (yrs)  
   All (mean +/- STD) 43.9 (13.5) 
   18 - 24  10 (8.5) 
   25 to 30  13 (11.0) 
   31 to 35  16 (13.6) 
   36 to 40  9 (7.6) 
   41 to 45  17 (14.4) 
   46 to 50  9 (7.6) 
   51 to 55  14 (11.9) 
   56 to 60  14 (11.9) 
   61 to 65  12 (10.2) 
   66 and older 4 (4) 
Gender  
   Male 82 (68.3) 
   Female 37 (30.8) 
   Transgender  1 (0.8) 
Race  
  White/Caucasian 53 (46.1) 
   Black 30 (26.1) 
   American Indian/Alaskan Native 6 (5.2) 
   Asian/Pacific Islander 2 (1.7) 
   Multiple Races 17 (14.7) 
Ethnicity  
   Non-Hispanic/Non-Latino 80 (74) 
   Hispanic/Latino 28 (26) 
Highest Education Completed  
   Graduated College 15 (12.8) 
   Some College 27 (23.1) 
   Graduated High School 39 (33.3) 
   11th Grade 11 (9.4) 
   10th Grade 12 (10.3) 
   9th Grade or Lower 12 (10.3) 
   Did Not Attend School 1 (0.9) 
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Length of Stay at This Shelter  
   Less Than One Week 13 (10.8) 
   One Month 34 (28) 
   2 to 6 Months 34 (28) 
   6 to 12 Months 5 (4.2) 
   More Than a Year 11 (9.2) 
Length of Homelessness  
   Less Than One Week 8 (6.8) 
   One Month 19 (16.2) 
   2 to 6 Months 29 (24.8) 
   6 to 12 Months 12 (10.3) 
   More Than a Year 49 (41.9) 
Been to Prison  
   Yes 62 (51.7) 
   No 49 (40.8) 
   Prefer Not to Answer 9 (7.5) 
Know What Hep C is?  
   Yes 83 (69.2) 
   No 24 (20.0) 
   Not Sure 13 (10.8) 
Where Hear about Hep C?  
   Doctor 45 (51.1) 
   Friend 4 (4.6) 
   Family 5 (5.7) 
   Other 34 (38.6) 
Ever Tested for Hep C?  
   Yes 80 (67.8) 
   No 27 (22.9) 
   Don't Know 11 (9.3) 
Do You Have Hep C?  
   Yes 15 (13.0) 
   No 88 (76.5) 
   Don't Know 12 (10.4) 
   Prefer Not to Answer 0 (0) 
Most Recent Doctor's Visit  
   Within the Past Month 66 (55.5) 
   Within the Past 6 Months 31 (26.1) 
   Within the Past Year 13 (10.9) 
   Not Seen in the Past Year 4 (3.4) 
   Not Seen in the Past 5 Years 5 (4.2) 
How Likely Are You To:  
Get Screened at a Hospital  
   Not at all Likely 32 (28.8) 
   Somewhat Unlikely 9 (8.3) 
   Neither Likely nor Unlikely 10 (9.0) 
   Somewhat Likely 22 (19.8) 
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   Very Likely 38 (34.2) 
Get Screened at a Health Clinic  
   Not at all Likely 27 (25.0) 
   Somewhat Unlikely 9 (8.3) 
   Neither Likely nor Unlikely 13 (12.0) 
   Somewhat Likely 23 (21.3) 
   Very Likely 36 (33.3) 
Get Screened at Your Shelter  
   Not at all Likely 38 (34.6) 
   Somewhat Unlikely 10 (9.1) 
   Neither Likely nor Unlikely 9 (8.2) 
   Somewhat Likely 21 (19.1) 
   Very Likely 67 (29.1) 
Get Treatment if I Had Hep C   
   Not at all Likely 16 (14.7) 
   Somewhat Unlikely 4 (3.7) 
   Neither Likely nor Unlikely 9 (8.3) 
   Somewhat Likely 13 (11.9) 
   Very Likely 67 (61.5) 
Seek Help to Stop Substance Abuse  
   Not at all Likely 27 (25.7) 
   Somewhat Unlikely 2 (1.9) 
   Neither Likely nor Unlikely 10 (9.5) 
   Somewhat Likely 8 (7.6) 
   Very Likely 58 (55.2) 
              
The majority of survey respondents, 33.3%, had a high school education or GED 
equivalent (n=39), with 23% (n=27) indicating they had attended some college, 12.8% (n=15) 
having attended college, and the remainder of the participants had completed 11th grade or 
below.  Only one person indicated that they did not attend school at all.   
Forty-eight percent of the respondents (n=56) noted that they have been homeless fewer 
than six months, while 41.9% (n=49) indicated they have been homeless for over a year. Ten 
percent (n=12) said they have been homeless six to twelve months.   
Over half of the participants indicated they had seen a doctor within the past month 
(n=66), and nearly a quarter said they seen a doctor within the past six months (n=31).  In sum, 
92.5% of the people had had a doctor’s visit within the past year (n=110).  Only 3.4% (n=4) had 
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not seen a doctor in the past year, and 4.2% (n=5) had not been to the doctor’s in the past five 
years. 
When asked about likelihood to get screened for Hepatitis C at various locations, most 
responses were equally divided among those who indicated they were ‘Not at all likely’ or ‘Very 
likely’ – the two opposite responses.  For likelihood to get screened at a hospital, 28.8% (n=32) 
indicated they were not at all likely while 34% (n=38) were very likely.  For screenings at a 
health clinic the results were similar:  25% (n=27) were not at all likely while 33% (n=36) were 
very likely.  For shelter screenings, 34% (n=38) were not at all likely compared to 29% (n=67) 
were very likely.   
The responses were overwhelmingly favorable for likelihood to get treatment if the 
screening showed the person had the disease.  Over 60% (n=67) said they would be very likely to 
seek treatment if they had the disease, while only 14.7% (n=16) noted they would be not at all 
likely to get treatment.  When asked if they would seek help to stop substance abuse, if they had 
it, 55.2% (n=58) answered they would be ‘very likely’ to do so, while 25.7% (n=27) said they 
would not at all be likely to do so.   
Knowledge of Hepatitis C 
Of the ten questions in the survey, the three questions that received the highest correct 
responses as shown in Table 2 include: knowing that a common method for Hepatitis C infection 
is by sharing needles and other equipment to inject drugs (83.0%) understanding that Hepatitis C 
is a highly contagious disease (72.5%), and that Hepatitis C is a serious, long-term illness if not 
treated (65.8%).  The three least known facts appear to be correctly knowing that there is no 
vaccine (18.3%); not knowing that Hepatitis C only affects the liver (27.5%); and that treatment 
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for the disease involves taking more than one pill (32.5%), with more than three-quarters of the 
participants not realizing it is a multi-week treatment.  
The mean score for the 10-question Hepatitis C section (i.e., the percentage of correct 
answers) was 48.6% as shown in Table 3, indicating that this population does not know as much 
as perhaps it thought about Hepatitis C despite being a vulnerable group for the disease. The 
question ‘Do you know what Hepatitis C is’ that was asked earlier in the survey, however, 
showed that 69% (n=83) indicated that they did.  Moreover, the fact that more than 92.5% 
(n=110) of all survey respondents reported going to a doctor within the past year or less indicates 
that discussions about Hepatitis C may not be occurring.  
Table 2. Hepatitis C Quiz Correct Responses 
Question 
# 
Question 
n (%) 
Correct  
Q1 Hepatitis C is a contagious disease. 87 (72.5) 
Q2 Fatigue is a common symptom of early stages of Hepatitis C. 55 (45.8) 
Q3 A common way people become infected with Hepatitis C is by sharing 
needles and other equipment to inject drugs. 
100 (83) 
Q4 There is a vaccine for Hepatitis C. 22 (18.3) 
Q5 Hepatitis C is a serious, long-term illness if not treated. 79 (65.8) 
Q6 Most people who have Hepatitis C do not feel sick. 50 (41.7) 
Q7 If I already had a Hepatitis C screening test in the past I do not need to 
be tested again. 
57 (47.5) 
Q8 There is no benefit to getting treatment for Hepatitis C if I continue to 
use intravenous drugs. 
54 (45) 
Q9 Hepatitis C only affects the liver. 33 (27.5) 
Q10 Treatment for Hepatitis C involves taking only one pill. 39 (32.5) 
 
Appendices C through E show each of the responses to the ten questions of the Hepatitis C quiz 
by gender, education level, and age.  
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Table 3. Hepatitis C Quiz Mean and Median Scores 
 Mean Correct Score Median Score 
All  48.6% 55% 
Gender Male 45.7% 50% 
Female 52.9% 60% 
Education 
Level 
Graduated from College 56.0% 60% 
Some College 49.6% 60% 
High School or GED 47.2% 50% 
11th Grade or Lower 44.6% 50% 
Age 18 to 24 Years 39.2% 45% 
25 to 30 Years 44.6% 50% 
31 to 50 Years 50.4% 50% 
51 Years and Older 48.6% 55% 
 
Using a 70% quiz score as an arbitrary minimum ‘passing’ grade, the results varied by 
strata.  As shown in Table 3, women had slightly higher median and mean scores as compared to 
their male counterparts. Those with a college degree scored the highest, followed by the 
individuals who attended some college.  The participants with a high school education or GED 
scored slightly higher than those with an 11th grade education or lower, both groups in the 
bottom half of the rankings. From an age perspective, those aged 18 to 24 scored the lowest 
whereas those 31 to 50 achieved the highest scores.   
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Table 4. Willingness to be Screened for Hepatitis C by Demographic Factor 
Variable 
Willingness to be Screened for 
Hepatitis C    P value 
YES NO 
Male 67.1 % 32.9 % 
0.45 
Female 74.3 % 25.7 % 
Ages 18-30 5.4 % 3.2 %  
0.88 Ages 31-50 34.4 % 3.2 % 
51 and older 29.0 % 16.1 % 
White/Caucasian 70.2 % 29.8 %  
 
 
0.50 
Black 70.8 % 29.2 % 
Hispanic 66.7 % 33.3 % 
American Indian/Alaskan Native 100 % 0 % 
Asian/Pacific Islander 50.0 % 50.0 % 
Multiple Races 64.3 %  35.7 % 
Graduated College 50.0 % 50.0 %  
0.28 
Some College 80.8 % 19.2 % 
High School 66.7 % 33.3 % 
9th – 11th Grade or Lower 70.6 % 29.4 % 
Ever Been in Prison 77.4 % 22.6 % 
0.03* 
Never Been in Prison 58.1 % 41.9 % 
Homeless One Month or Less 76.2 % 23.8 % 
0.19 Homeless 2 to 12 Months 57.9 % 42.1 % 
Homeless More Than One Year 74.4 % 25.6 % 
        * p<.05 
Willingness to Be Screened for Hepatitis C 
Table 4 depicts the willingness to be screened by the variables of gender, age, race, 
education level, prison, and length of time homeless.   Overall, women (74.3%) were more 
willing to be screened than men (67.1%).  Both White and Black participants indicated a 70% 
willingness to be screened, with Hispanics slightly lower at 66.7%.  Those aged 31 to 50 had the 
highest percentage of willingness (34.4%) as compared to other age groups, and those with some 
college education had the highest percentage (80.8%) as compared with any of the other 
educational groupings or any strata – including gender and age.  The age group that indicated the 
lowest interest in screening where those with a college degree, who were evenly divided at 50% 
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between being willing to be screened or not.  The participants who indicated they had been in 
prison showed a higher willingness to be screened (77.4%) as compared with their peers who 
stated they had never been incarcerated.  The previous prison experience variable is the only 
variable with statistical significance (p=0.03).  In the final grouping by length of time homeless, 
both those who had been homeless for one month or less (76.2%) as well as those who had 
indicated they had been homeless for more than a year (74.4%) both showed a stronger 
willingness to be screened as compared with those who have experienced homelessness between 
two and twelve months (57.9%). 
Factors that Predict Willingness to be Screened 
 We explored which potential predictive factors surfaced as the most salient when 
controlling for all factors simultaneously in a multivariate logistic regression model. Table 5 
shows the results of the baseline model that examined age, gender, and education.  Model 2 
added having time spent in prison to the baseline model, Model 3 added included previous 
Hepatitis C testing and Model 4 added whether or not having had a doctor visit within the past 
year could predict the willingness of a person experiencing homelessness to be screened.   
All models indicate that age was not associated with willingness to be screened, with all 
point estimates close to 1.00.  Increased level of education appears to have a modest association 
with one’s willingness to be screened, with ORs ranging from 0.98 to 1.14 yet all 95% CIs 
crossed 1.00 in each model. Males appear to be more willing to be screened (ORs ranged from 
1.90 to 2.9) yet 95% CIs all included 1.00 in the models.  Among those who have not spent time 
in prison, they were 39% less willing to be screened (95% CI 0.15-0.98), compared to those who 
had served in Model 2, yet this effect was attenuated somewhat in Models 3 and 4 when 
accounting for having been tested before and/or having seen a doctor in the past year. Similarly, 
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those who have not had a Hepatitis C test in the past were 44% (95% CI 0.23-0.85; Model 3) or 
46% (95% CI 0.23-0.91, Model 4) less willing to be screened than those who have been 
previously tested. Lastly, having seen a doctor in the past 12 months did not appear to have an 
influence on willingness to be screened. 
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Table 5. Multivariate Analysis of Predictors of Willingness to be Screened 
 Univariate Baseline Model1 Model 2 Model 3 Model 4 
OR                95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI 
Age 1.01 0.97-1.04 1.02 0.98-1.1 1.02 0.98-1.05 1.01 0.98-1.05 1.01 0.97-1.05 
Sex 
Males vs Females 
1.40 0.57-3.50 1.90 0.70-5.1 2.29 0.80-6.49 2.26 0.63-5.18 2.24 0.73-6.85 
Education 1.08 0.81-1.43 1.14 0.84-1.6 1.07 0.79-1.46 1.00 0.77-1.45 0.98 0.72-1.37 
History of Prison 
No vs Yes 
0.41 0.17-0.95   0.39 0.15-0.98 0.42 0.15-1.07 0.40 0.15-1.07 
Tested Before 
Yes vs No 
0.39 0.20-0.75     0.46 0.23-0.90 0.46 0.23-0.91 
Doctor Visit w/in 1 year 
Yes vs No 
0.89 0.60-1.34       0.97 0.62-1.53 
1 All models simultaneously adjusted for all variables.  
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Discussion 
Multivariate analyses revealed that those who were tested before were far less likely to 
express willingness to be tested again (OR=0.46 Model 3; OR=0.46 Model 4) as were those who 
did not have a history of being in prison (OR=0.39, Model 2; OR=.42 Model 3). The 
implications of these findings are that those who have been tested do not see the need, which is 
problematic if they continue high risk behaviors. Other potential predictors (i.e., sex, education, 
doctor visit within one year) were not associated with willingness to be tested when controlling 
for all variables. 
In this cross-sectional study of 120 residents of five homeless shelters across 
Connecticut, we found that most participants were less informed about specific aspects of 
Hepatitis C compared to how they reported their overall understanding. That is, on the general 
knowledge question, most (83%) survey participants indicated they knew about Hepatitis C yet 
the mean score was 48.6% for the 10-item quiz.  This finding of poor specific knowledge is 
consistent with the literature regarding the general population (Vermunt, 2015). A number of 
studies in different countries reported that the general population correctly answered between 
40% and 60% of knowledge questions surrounding Hepatitis C (Vermunt, 2015).  In our study, 
the least known fact about Hepatitis C was the misbelief that there is a vaccine for Hepatitis C 
with only 18.3% (n= 22) correctly answering the question that there is no vaccine. Similarly, the 
understanding that Hepatitis C affects the liver was answered correctly by only 27.5% (n=33) of 
those surveyed.   
The length of time stayed at their current shelter was not clearly answered.  The original 
question on the survey asked what date the person arrived at the shelter.  However, this question 
was not approved during the IRB process as it could be an identifying data point.  The IRB 
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recommended that the question be modified to include a separate field for year, month, and day 
and is reflected in the final version of the survey shown in Appendix A.  This question, however, 
generated many queries among the participants, and based on the responses many did not 
understand how to complete it.  As a result, this information was not used for additional analysis.   
There were a disproportionate number of Black respondents according to the general 
population which is estimated to be 10% in Connecticut (DataUSA, 2020).  A quarter of the 
respondents (n=30) were Black as compared to 46% (n=53) White, which reflects the homeless 
population overall where Blacks are overrepresented in the homeless system. 
Who is Willing to Be Screened? 
Among those experiencing homelessness, our descriptive findings revealed that the 
groups most willing to be screened were: women (74.3%), those aged 31 – 50 years (34.4%), and 
those who have been to prison (77.4%), and, those with some college education (80.8%).  Of 
concern, youth, aged 18 to 24, exhibited very low willingness to be screened (5.4%) given that 
the CDC has reported that Hepatitis C infections have tripled in the past few years as a result of 
the opioid crisis among the younger generations (CDC, 2018).  The analysis revealed there was 
not a clear trend.  Those who had spent the most time in shelter had roughly the same percentage 
of willingness to be screened as those who had only spent one month in shelter.  
Knowledge Status 
The general Hepatitis C knowledge quiz revealed that the overall mean score was a ‘low’ 
grade (48.6%), perhaps indicating that there are substantial opportunities for providers to educate 
their homeless patients about this disease on a regular basis.  According to the most recent 
Hepatitis C guidelines, risk-based Hepatitis C testing alone is not effective nor recommended 
(Spach, 2020).  The conversation must be on-going, and according to the latest recommendation 
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in March of 2020 of the U.S. Preventative Services Task Force (USPSTF), routine screening for 
all adults aged 18 to 79 is recommended (Spach, 2020).  Although most adults will require only 
one screening, periodic screening is recommended for those with on-going risk, such as those 
experiencing homelessness.  The data from this study present an opportunity to educate providers 
about the importance of discussions with patients who are experiencing homelessness regarding 
the risks and need for screenings and treatment.  
There were a few people (n=12) who indicated they wanted the researcher to ask them 
the questions since they couldn’t read the survey (did not have their reading glasses or could not 
read).  The researcher anticipated that this may result in a hesitancy or unwillingness to respond 
‘Yes’ to some questions, including if they spent time in prison, in front of the researcher.  This 
was not the case, and many of the respondents had no qualms about sharing they spent time in 
prison.  The researcher, however, did suspect that a few individuals may have falsely stated they 
had attended college, or attended some college, based upon their body language and hesitancy in 
answering that question.   
Qualitative Observations and Lessons Learned 
During discussions after the survey, several residents indicated that they were interested 
in finding out more about Hepatitis C and if they were at risk.  Many indicated that the shelters 
require them to leave by 8am, and without employment or other places to go during the day, said 
that they often choose to go to the drug dealers a few streets away from the shelter as a means of 
passing time and as a way to cope with their bleak situation.  Learning that Hepatitis C is 
frequently spread by the sharing of intravenous drug needles and other equipment was of 
particular interest.  The knowledge quiz in the survey revealed that most respondents know this 
fact, yet are unaware of the dangers and lack of symptoms of Hepatitis C.   
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Some residents had confused Hepatitis B with Hepatitis C, again illustrating the lack of 
knowledge about the disease.  In any future study, it is recommended that informational flyers be 
distributed to the shelters about the topic after the survey is completed.  The researcher answered 
questions, however, it would have been helpful to have documentation to distribute to seize the 
opportunity to provide education on the disease to the broader audience.   
The questions about race and ethnicity posed more inquiries than expected.  A number of 
respondents indicated no specific race or ethnicity, but merely indicated ‘Puerto Rican’ on the 
form.  Others indicated ‘Hispanic’ for race and ethnicity, while some only indicated ‘Hispanic’ 
for the ethnicity but left the race field blank.  As a result, the ethnicity field was not leveraged in 
the data analysis. Any future surveys may consider using a guided interview approach to collect 
the data. 
Study Limitations 
While this study was cross-sectional study and therefore, we cannot address causation, 
we can assume that the direction of most effects is logical because the predictors were stable 
characteristics (e.g., education, sex, age). Yet, factors such as having seen a doctor recently 
indicating a greater willingness to be screened, could reflect having prior knowledge about 
Hepatitis C or other health matters as the trigger to visit the doctor. The study included a 
convenience sample of people experiencing homelessness who volunteered to take the survey, 
which may introduce self-selection bias.  The impact might be a higher response rate for 
indicating knowledge about the topic and a higher reported willingness to be screened than the 
general public.   Since the study collected data on both the independent and dependent variables 
from the same respondents at one point in time, the potential for common method bias and false 
internal consistency might be present in the data. The best counter to this would be to leverage a 
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separate data source, however, given the nature of this study this was not feasible as no external 
data source exists for this population for the questions asked.   
Questions specifically related to current or past substance use were omitted from this 
study primarily for facilitation of IRB submission and the HIPAA standards in an effort not to 
delay the IRB process for this survey, but should be asked in future research as they pertain 
directly to the transmission of Hepatitis C.  Given that only a handful of shelters were logistically 
feasible to survey for this study, sampling bias may be a factor as the survey was only 
administered in five shelters in Connecticut out of 63 emergency shelters in the state.  Although 
effort was be made to include a representative sample of shelters across each of the seven 
coordinated access networks in the state, not every shelter responded to the request to conduct 
the survey despite several email and phone call attempts.  It is possible that the clients who 
answered the survey do not represent the diversity of this population.  The researcher attempted 
to obtain a minimum of 140 surveys to allow for ten cases for each predictor variable, yet the 
number of usable surveys collected totaled 120.  Although the response rates for completion of 
the survey were very high overall, the lower collection rate may be attributed to the fact that 
there were two relatively warm winter evenings when the survey was conducted, potentially 
leading fewer people into shelters on those nights. 
Conclusions 
Implications for Public Health Practice and Policy 
This research has significant public health implications as it will fill an important 
research gap in the literature.  No studies to our knowledge addressed the association of the 
awareness of Hepatitis C risks and transmission among those experiencing homelessness and 
their willingness to get screened for the deadly virus.  Perhaps more importantly, the results of 
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this research could inform interventions and policy around this vulnerable and marginalized 
population that is highly likely to have Hepatitis C.  For example, shelters could offer 
informational flyers concerning the risks of Hepatitis C and the need to be screened.  Providers 
could play a more active role in discussing this disease with homeless patients and encouraging 
testing at frequent intervals.  Long-term policy changes could involve the frequency of 
screenings in convenient locations as well as increased funding by insurance companies. 
Working together, the currently fragmented standards would be standardized to ensure frequent 
and fully-covered screenings for this vulnerable population. 
In 2017, the Infectious Diseases Society of America (IDSA) and the American 
Association for the Study of Liver Disease (AASLD) published new guidelines on the treatment 
of Hepatitis C (AASLD IDSA, 2018). These new guidelines detail the use of a new short 
duration treatment option, unlike the older, long-term previous treatment such as interferon-
based therapy.  Much of the research conducted after these new guidelines focuses on the 
benefits of the new Direct-Acting Antiviral (DAA) treatment and the potential to exponentially 
reduce the burden of HCV.  This new treatment would be better suited for the homeless 
population not only because of the shorter treatment duration, but also because it has high rates 
of clinical effectiveness and few side effects (Aisyah et al., 2018).  This further necessitates the 
need for screening those experiencing homelessness and the need for additional research to 
understand the best strategies to maximize screening and, ultimately, treatment participation.   
Moreover, with the advent of the Medicaid expansion program, many states provide low-
income adults with greater access to healthcare services.  Although a broad number of states 
cover treatment of Hepatitis C, many still impose restrictions that prevent access.  According to a 
report in 2018, 12 states only covered treatment for those with advanced liver fibrosis, 9 states 
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required treatment to be prescribed by a liver disease specialist, and 20 states require a six-month 
period of abstinence from drug or alcohol use (Long, 2018). These policies, many of which are 
not evidence-based, must be reviewed and modified to become more inclusive in order to 
provide access to treatment for the deadliest blood-borne disease in the US.   
The ultimate public health goal of this research, however, is to reduce and eventually 
eliminate HCV transmission per WHO goals. Given that the prevalence of HCV is high among 
people who inject drugs, combined with the fact that intravenous drug use is rising, particularly 
with the opioid epidemic, examining the awareness and knowledge of this disease is essential 
among marginalized populations, particularly those experiencing homelessness.  
HCV screening is a low-cost and effective intervention, and even routine HCV screening 
is considered cost-effective in this population given the high incidence of intravenous drug use. 
Under the Affordable Care Act (ACA), preventive screening for Hepatitis C is covered (HHS, 
2016). Identifying the extent to which the homeless population understands the health risks of 
HCV and behaviors that lead to HCV transmission should help target programs and educational 
material to this community.  Moreover, policy changes could help improve healthcare coverage 
for treatment, which is expensive, for those experiencing homelessness which would have a 
significant impact on public health. 
This awareness, combined with convenient screening and treatment locations designed 
specifically for this population, could significantly reduce the spread of this deadly disease, 
lower overall medical costs since patients would be treated early in the disease, and decrease and 
eventually eliminate the prevalence of HCV, thereby making a considerable impact on the public 
health practice.  Hepatitis C often has a stigma attached to it, resulting in a hesitation or 
avoidance of discussion around the topic.  This initial phase of research would help to start the 
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conversation on this topic and provide data that reveal the need to educate, screen, and treat the 
homeless population, which is highly likely to have this disease.   
The analysis of the existing literature reveals that more research is needed to identify 
what targeted strategies should be leveraged to increase Hepatitis C screening among vulnerable 
populations.  One study focuses on addressing health disparities in Hepatitis C screening, and 
although not specifically focused on the homeless population, this study provides insight into 
general best practices for racial and ethnic minorities as well as the socio-economically 
disadvantaged (Jain et al., 2019).  These insights include an educational component, an 
automatic alert in an electronic medical record (EMR) to notify the provider when a patient 
attended a clinic and had no prior HCV antibody recorded in the system and increasing clinic 
capacity to evaluate patients.  Other studies focus on community screening programs targeted to 
those experiencing homelessness and the need to tailor services for this population in order to 
encourage follow-up visits with primary care providers (Fuster & Gelberg, 2019).   
Each study provides unique insights, but few provide clear, targeted strategies.  Further 
research is warranted not only because the topic is timely, as targeted populations have grown, 
but also because many of these populations include people experiencing homelessness. Defining 
a clear strategy for screening would help prevent the spread of HCV.  To do so, however, it is 
imperative to understand what factors predict the willingness of a person experiencing homeless 
to get screened for Hepatitis C in the first place. Understanding these factors, or the general level 
of awareness of the disease, is a critical step in developing programs to help this population 
realize the severity of the disease and the importance of early screening and treatment. 
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Appendix A. Survey 
HEPATITIS C SURVEY 
Thank you for your willingness to complete this short survey. These questions will help us to understand 
how much is known about Hepatitis C and clients’ willingness to learn more about this disease.  All 
responses are completely confidential and will not be shared with anyone, including here at the shelter.  
This information will be used entirely for research purposes.   
Questions with an * indicate these questions are required, but you may skip any questions that you do 
not feel comfortable answering.  Completion and return of the survey imply voluntary participation.  You 
may place your completed survey in the secure box provided.  
 
Research question: Which factors predict willingness of a person experiencing homelessness to be 
screened for Hepatitis C? 
 
GENERAL QUESTIONS 
 
1. *What is your age?  _______________ 
 
2. *What is your gender? 
Male 
Female 
Prefer not to answer 
Other (please specify) ____________________________________________________________ 
 
3. *Which race best describes you? (Please choose only one.) 
American Indian or Alaskan Native 
Asian / Pacific Islander 
Black or African American 
White/Caucasian 
Multiple races (please specify) _____________________________________________________ 
 
4. *Which ethnicity best describes you? (Please choose only one.) 
Hispanic/Latino 
Non-Hispanic/Non-Latino 
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5. *What is the highest level of education you have completed? 
Did not attend school 
9th grade or lower 
10th grade 
11th grade 
Graduated from high school 
Some college 
Graduated from college 
 
6. *How long have you been in this shelter?  _______years _______months _______days 
 
7. *How long have you been homeless? 
Less than one week 
One month  
2 to 6 months 
6 to 12 months 
More than one year 
 
8. *Have you ever been to prison? 
Yes 
No 
Prefer not to answer 
 
QUESTIONS ABOUT HEPATITIS C 
 
9. *Do you know what Hepatitis C is? 
Yes 
No 
Not sure 
 
10. If you answered ‘Yes’ to Question 9, where did you hear about Hepatitis C? 
Doctor 
Friend 
Family 
Other (please specify) _________________________________________________________ 
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11. *Have you ever been tested for Hepatitis C? 
Yes 
No  
I don't know 
 
12. *Do you have Hepatitis C? 
Yes 
No 
I don't know 
Prefer not to answer 
 
 
13. *When was your most recent doctor’s visit?  
Within the past month 
Within the past six months 
Within the past year 
I haven’t seen a doctor in the past year 
I haven’t seen a doctor in the past 5 years 
Other (please specify) __________________________________________________________ 
 
 
Please select the answer that best describes your understanding of the following: 
14.  *Hepatitis C is a contagious disease. True False Unsure 
15.  *Fatigue is a common symptom of early stages of Hepatitis C. True False Unsure 
16.  *A common way people become infected with Hepatitis C is by sharing 
needles and other equipment to inject drugs. 
True False Unsure 
17.  *There is a vaccine for Hepatitis C. True False Unsure 
18.  *Hepatitis C is a serious, long-term illness if not treated. True False Unsure 
19.  *Most people who have Hepatitis C do not feel sick. True False Unsure 
20.  *If I already had a Hepatitis C screening test in the past I do not need to 
be tested again. 
True False Unsure 
21.  *There is no benefit to getting treatment for Hepatitis C if I continue to 
use intravenous drugs. 
True False Unsure 
22.  *Hepatitis C only affects the liver. True False Unsure 
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23.  *Treatment for Hepatitis C involves taking only one pill. True False Unsure 
How likely are you to do each of the following?  
 
 Not at all 
likely  
Somewhat 
Unlikely 
Neither likely 
nor unlikely 
Somewhat 
Likely 
Very 
Likely 
24. *Go to a Hepatitis C screening at a 
local hospital. 
1 2 3 4 5 
25. *Go to a Hepatitis C screening at 
a local health clinic. 
1 2 3 4 5 
26. *Go to a Hepatitis C screening at 
my shelter. 
1 2 3 4 5 
27. *Get treatment for Hepatitis C if 
the screening revealed I had it. 
1 2 3 4 5 
28. Seek help to stop substance 
abuse (if applicable). 
1 2 3 4 5 
 
Thank you for your participation in this survey.  Your answers will remain completely confidential and 
will not be shared with anyone.   
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Appendix B. Hepatitis C Quiz Responses by Gender 
Correct responses shown in bold. 
 Male Female 
 True False Unsure True False Unsure 
Q1. Hepatitis C is a contagious disease. 57 
(49) 
10 
(8.6) 
12 
(10.3) 
30 
(25.9) 
3 
(2.6) 
4 
(3.5) 
Q2. Fatigue is a common symptom of 
early stages of Hepatitis C. 
33 
(29.2) 
9  
(8.0) 
34 
(30.1) 
22 
(19.5) 
3 
(2.7) 
12 
(32.7) 
Q3. A common way people become 
infected with Hepatitis C is by sharing 
needles and other equipment to inject 
drugs. 
66 
(56.9) 
3  
(2.6) 
9    
(7.8) 
34 
(29.3) 
4 
(3.5) 
3  
(2.6) 
Q4. There is a vaccine for Hepatitis C. 42 
(35.9) 
15 
(12.8) 
22 
(18.8) 
21 
(18) 
7 
(6.0) 
10 
 (8.6) 
Q5. Hepatitis C is a serious, long-term 
illness if not treated. 
52 
(46.4) 
6  
(5.4) 
18 
(16.1) 
27 
(24.1) 
2 
(1.8) 
7  
(6.3) 
Q6. Most people who have Hepatitis C 
do not feel sick. 
32 
(28.1) 
20 
(17.5) 
26 
(22.8) 
18 
(15.8) 
7 
(6.1) 
11   
(9.7) 
Q7. If I already had a Hepatitis C 
screening test in the past I do not need 
to be tested again. 
17 
(14.7) 
39 
(33.6) 
22 
(19.0) 
8  
(6.9) 
18 
(15.5) 
12 
(10.3) 
Q8. There is no benefit to getting 
treatment for Hepatitis C if I continue 
to use intravenous drugs. 
15 
(13.2) 
37 
(32.5) 
24 
(21.1) 
8  
(7.0) 
17 
(14.9) 
13 
(11.4) 
Q9. Hepatitis C only affects the liver. 21 
(18.1) 
23 
(19.8) 
34 
(29.3) 
12 
(10.3) 
14 
(12.1) 
12 
(10.3) 
Q10. Treatment for Hepatitis C 
involves taking only one pill. 
13 
(11.2) 
23 
(19.8) 
42 
(36.2) 
3  
(2.6) 
16 
(13.8) 
19 
(16.4) 
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Appendix C. Hepatitis C Quiz Responses by Education Level 
Correct responses shown in bold. 
 Graduated from 
College 
Completed Some 
College 
Completed High School Completed 11th Grade 
or Lower 
 True False Unsure True False Unsure True False Unsure True False Unsure 
Q1. Hepatitis C is a 
contagious disease. 
13 
(11.2) 
1 
(0.9) 
1 
(12.9) 
20 
(17.2) 
3 
(2.6) 
4 (3.5) 29 
(25) 
5 
(4.3) 
4 
(3.5) 
25 
(21.6) 
4 
(3.5) 
7 
(6.0) 
Q2. Fatigue is a common 
symptom of early stages of 
Hepatitis C. 
10 
(8.9) 
0 
(0) 
5 
(4.4) 
13 
(11.5) 
3 
(2.7) 
11 
(9.7) 
17 
(15.0) 
5 
(4.4) 
13 
(11.5) 
15 
(13.2) 
4 
(3.5) 
17 
(15.0) 
Q3. A common way people 
become infected with 
Hepatitis C is by sharing 
needles and other 
equipment to inject drugs. 
12 
(10.3) 
2 
(1.7) 
1 
(0.9) 
22 
(19.0) 
1 
(0.9) 
3 
(2.6) 
34 
(29.3) 
0 
(0) 
4 
(3.5) 
32 
(27.6) 
1 
(0.9) 
4 
(3.5) 
Q4. There is a vaccine for 
Hepatitis C. 
7 
(6.0) 
5 
(4.3) 
3 
(2.6) 
14 
(12.0) 
6 
(5.1) 
7 
(6.0) 
20 
(17.1) 
7 
(6.0) 
11 
(9.4) 
22 
(18.8) 
4 
(3.4) 
11 
(9.4) 
Q5. Hepatitis C is a serious, 
long-term illness if not 
treated. 
12 
(10.7) 
0 
(0) 
3 
(2.7) 
19 
(17.0) 
4 
(3.6) 
4 
(3.6) 
21 
(18.8) 
4 
(3.6) 
9  
(8.0) 
27 
(24.1) 
0  
(0) 
9  
(8.0) 
Q6. Most people who have 
Hepatitis C do not feel sick. 
5 
(4.4) 
4 
(3.5) 
5 
(4.4) 
14 
(12.3) 
6 
(5.3) 
7 
(6.1) 
14 
(12.3) 
10 
(8.8) 
13 
(11.4) 
17 
(14.9) 
7 
(6.1) 
12 
(10.5) 
Q7. If I already had a 
Hepatitis C screening test 
in the past I do not need to 
be tested again. 
2 
(1.7) 
11 
(9.5) 
2 
(1.7) 
5 
(4.3) 
14 
(12.1) 
8 
(6.9) 
8 
(6.9) 
20 
(17.2) 
9 
 (7.8) 
10 
(8.6) 
12 
(10.3) 
15 
(12.9) 
Q8. There is no benefit to 
getting treatment for 
Hepatitis C if I continue to 
use intravenous drugs. 
1 
(0.9) 
8 
(7.0) 
6 
(5.3) 
7 
(6.1) 
12 
(10.5) 
8 
(7.0) 
9 
(7.9) 
17 
(14.9) 
11 
(9.7) 
6 
(5.3) 
17 
(14.9) 
12 
(10.5) 
Q9. Hepatitis C only affects 
the liver. 
3 
(2.6) 
8 
(6.9) 
4 
(3.5) 
6 
(5.2) 
8 
(6.9) 
12 
(10.3) 
10 
(8.6) 
12 
(10.3) 
16 
(13.8) 
14 
(12.1) 
9 
(7.8) 
14 
(12.1) 
Q10. Treatment for 
Hepatitis C involves taking 
only one pill. 
2 
(1.7) 
5 
(4.3) 
8 
(6.9) 
4 
(3.5) 
8 
(6.9) 
14 
(12.1) 
4 
(3.5) 
15 
(12.9) 
19 
(16.4) 
6 
(5.2) 
11 
(9.5) 
20 
(17.2) 
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Appendix D. Hepatitis C Quiz Responses by Age 
Correct responses shown in bold. 
 18-24 Years 25-30 Years 31-50 Years 51 -71 Years 
 True False Unsure True False Unsure True False Unsure True False Unsure 
Q1. Hepatitis C is a 
contagious disease. 
5 
(4.3) 
4 
(3.5) 
3 
(10.3) 
10 
(8.6) 
2 
(1.7) 
1  
(0.9) 
40 
(34.5) 
3 
(2.6) 
7  
(6.0) 
32 
(27.6) 
4 
(3.5) 
5 
 (4.3) 
Q2. Fatigue is a common 
symptom of early stages of 
Hepatitis C. 
6 
(5.3) 
1 
(0.9) 
4  
(3.5) 
7 
(6.2) 
0  
(0) 
6  
(5.3) 
20 
(17.7) 
7 
(6.2) 
22 
(19.5) 
22 
(19.5) 
4 
(3.5) 
14 
(12.4) 
Q3. A common way people 
become infected with 
Hepatitis C is by sharing 
needles and other equipment 
to inject drugs. 
8 
(6.9) 
0  
(0) 
4  
(3.5) 
13 
(11.2) 
0  
(0) 
0  
(0) 
45 
(38.8) 
1 
(0.9) 
4 
 (3.5) 
34 
(29.3) 
3 
(2.6) 
4  
(3.5) 
Q4. There is a vaccine for 
Hepatitis C. 
7 
(6.0) 
1 
(0.9) 
4  
(3.4) 
6 
(5.1) 
1 
(0.9) 
6   
(5.1) 
31 
(26.5) 
10 
(8.6) 
10 
(8.6) 
19 
(16.2) 
10 
(8.6) 
12 
(10.3) 
Q5. Hepatitis C is a serious, 
long-term illness if not 
treated. 
6 
(5.4) 
2 
(1.8) 
4  
(3.6) 
7 
(6.3) 
1 
(0.9) 
5   
(4.5) 
35 
(32.3) 
4 
(3.6) 
8 
 (7.1) 
31 
(27.7) 
1 
(0.9) 
8  
(7.1) 
Q6. Most people who have 
Hepatitis C do not feel sick. 
4 
(3.5) 
3 
(2.6) 
4 
 (3.5) 
4 
(3.5) 
2 
(1.8) 
5   
(4.5) 
23 
(20.2) 
14 
(12.3) 
14 
(12.3) 
19 
(16.7) 
8 
(7.0) 
14 
(12.3) 
Q7. If I already had a 
Hepatitis C screening test in 
the past I do not need to be 
tested again. 
0  
(0) 
4 
(3.5) 
7  
(6.0) 
4 
(3.5) 
6 
(5.2) 
3  
(2.6) 
11 
(9.5) 
26 
(22.4) 
14 
(12.1) 
10 
(8.6) 
21 
(18.1) 
10 
(8.6) 
Q8. There is no benefit to 
getting treatment for 
Hepatitis C if I continue to 
use intravenous drugs. 
3 
(2.6) 
5 
(4.4) 
4  
(3.5) 
2 
(1.8) 
4 
(3.5) 
6  
(5.3) 
9 
(7.9) 
28 
(24.6) 
13 
(11.4) 
9 
(7.9) 
17 
(14.9) 
14 
(12.3) 
Q9. Hepatitis C only affects 
the liver. 
2 
(1.7) 
5 
(4.3) 
5  
(4.3) 
3 
(2.6) 
4 
(3.5) 
6  
(5.2) 
14 
(12.1) 
17 
(14.7) 
19 
(16.4) 
14 
(12.1) 
11 
(9.5) 
16 
(13.8) 
Q10. Treatment for 
Hepatitis C involves taking 
only one pill. 
2 
(1.7) 
6 
(5.2) 
1  
(3.5) 
0  
(0) 
3 
(2.6) 
10 
(8.6) 
8 
(6.9) 
16 
(13.8) 
27 
(23.3) 
6 
(5.2) 
14 
(12.1) 
20 
(17.2) 
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Appendix E. Hepatitis C Quiz Grades by Gender, Education Level, and Age 
 Hepatitis C Quiz Grade   
 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
All  10 
(8.3) 
4 
(3.3) 
5 
(4.2) 
15 
(12.5) 
14 
(11.7) 
19 
(15.8) 
21 
(17.5) 
20 
(16.7) 
8 
(6.7) 
4 
(3.3) 
0  
(0) 
Gender Male 7 
(5.8) 
3 
(2.5) 
4 
(3.3) 
10 
(8.3) 
13 
(10.8) 
15 
(12.5) 
13 
(10.8) 
10 
(8.3) 
4 
(3.3) 
3 
(2.5) 
0  
(0) 
Female 3 
(2.5) 
1 
(0.8) 
1 
(0.8) 
5 
(4.2) 
1 
(0.8) 
4 
(3.3) 
8 
(6.7) 
10 
(8.3) 
4 
(3.3) 
1 
(0.8) 
0  
(0) 
Education 
Level 
Graduated from College 1 
(0.8) 
0  
(0) 
1 
(0.8) 
0  
(0) 
1 
(0.8) 
2 
(1.7) 
5 
(4.2) 
2 
(1.7) 
3 
(2.5) 
0  
(0) 
0  
(0) 
Some College 2 
(1.7) 
0  
(0) 
2 
(1.7) 
4 
(3.3) 
3 
(2.5) 
2 
(1.7) 
6 
(5.0) 
5 
(4.2) 
2 
(1.7) 
1 
(0.8) 
0  
(0) 
High School or GED 2 
(1.7) 
3 
(2.5) 
0  
(0) 
6 
(5.0) 
5 
(4.2) 
10 
(8.3) 
5 
(4.2) 
4 
(3.3) 
1 
(0.8) 
3 
(2.5) 
0  
(0) 
11th Grade or Lower 5 
(4.2) 
1 
(0.8) 
2 
(1.7) 
5 
(4.2) 
5 
(4.2) 
5 
(4.2) 
5 
(4.2) 
9 
(7.5) 
2 
(1.7) 
0  
(0) 
0  
(0) 
Age 18 to 24 Years 4 
(3.3) 
0  
(0) 
0  
(0) 
1 
(0.8) 
1 
(0.8) 
1 
(0.8) 
1 
(0.8) 
3 
(2.5) 
1 
(0.8) 
0  
(0) 
0  
(0) 
25 to 30 Years 0  
(0) 
1 
(0.8) 
1 
(0.8) 
1 
(0.8) 
3 
(2.5) 
4 
(3.3) 
1 
(0.8) 
2 
(1.7) 
0  
(0) 
0  
(0) 
0  
(0) 
31 to 50 Years 2 
(1.7) 
1 
(0.8) 
1 
(0.8) 
3 
(2.5) 
3 
(2.5) 
3 
(2.5) 
10 
(8.3) 
8 
(6.7) 
3 
(2.5) 
2 
(1.7) 
0  
(0) 
51 Years and Older 4 
(3.3) 
2 
(1.7) 
3 
(2.5) 
5 
(4.2) 
2 
(1.7) 
6 
(5.0) 
9 
(7.5) 
7 
(5.8) 
4 
(3.3) 
2 
(1.7) 
0  
(0) 
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Appendix F. Survey Code Book 
Question # Question Short Name Code Values 
Q1 Age Age The age of the person in years 
Q2 Gender Sex 1=Male 
2=Female 
3= Prefer not to answer 
4=Other 
Q3 Race Race 0=Hispanic 
1=White/Caucasian 
2= Black 
3= American Indian or 
Alaskan Native 
4= Asian/Pacific Islander 
5= Multiple Races 
Q4 Ethnicity Ethn 1=Non-Hispanic/Non-Latino 
2=Hispanic/Latino 
Q5 Highest Education Educ 1=Graduated from college 
2=Some college 
3=Graduated from high 
school 
4=11th grade 
5=10th grade 
6= 9th grade or lower 
7=Did not attend school 
Q6 
 
Q6A How long have you 
been at this shelter? YEARS 
Year The number of years the 
person has been at this 
shelter 
Q6B How long have you 
been at this shelter? 
MONTHS 
Month The number of months the 
person has been at this 
shelter 
Q6C How long have you 
been at this shelter? DAYS 
Day The number of days the 
person has been at this 
shelter 
Q7 How long have you been 
homeless 
HowLong 1=Less than one week 
2=One month 
3=2 to 6 months 
4=6 to 12 months 
5=More than one year 
Q8 Have you ever been to 
prison? 
Prison 1=Yes 
2=No 
3=Prefer not to answer 
Q9 Do you know what Hepatis 
C is? 
KnowHepC 1=Yes 
2=No 
3=Not sure 
Q10 If yes to Q9, where did you 
hear about Hepatitis C? 
Wherehear 1=Doctor 
2=Friend 
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Question # Question Short Name Code Values 
3=Family 
4=Other 
School, TV, Program, Prison, I 
had it/have it, Internet, Social 
Media 
Q11 Have you ever been tested 
for Hepatitis C? 
TestHepC 1=Yes 
2=No 
3=Don’t know 
Q12 Do you have Hepatitis C? HaveHepC 1=Yes 
2=No 
3=Don’t know 
4=Prefer not to answer 
Q13 When was your most recent 
doctor’s visit? 
DocVisit 1=Within past month 
2=Within past 6 months 
3=Within the past year 
4=I haven’t seen a doctor in 
the past year 
5= I haven’t seen a doctor in 
the past 5 years 
6=Other 
Q14 Hepatitis C is a contagious 
disease. 
Contag 1=True 
2=False 
3=Unsure 
Q15 Fatigue is a common 
symptom of early stages of 
Hepatitis C. 
Fatigue 1=True 
2=False 
3=Unsure 
Q16 A common way people 
become infected with 
Hepatitis C is by sharing 
needles and other 
equipment to inject drugs. 
Needles 1=True 
2=False 
3=Unsure 
Q17 There is a vaccine for 
Hepatitis C. 
Vaccine 1=True 
2=False 
3=Unsure 
Q18 Hepatitis C is a serious, 
long-term illness if not 
treated. 
Serious 1=True 
2=False 
3=Unsure 
Q19 Most people who have 
Hepatitis C do not feel sick. 
FeelSick 1=True 
2=False 
3=Unsure 
Q20 If I already had a Hepatitis C 
screening test in the past I 
do not need to be tested 
again. 
Retest 1=True 
2=False 
3=Unsure 
Q21 There is no benefit to 
getting treatment for 
IVBenefit 1=True 
2=False 
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Question # Question Short Name Code Values 
Hepatitis C if I continue to 
use intravenous drugs. 
3=Unsure 
Q22 Hepatitis C only affects the 
liver. 
Liver 1=True 
2=False 
3=Unsure 
Q23 Treatment for Hepatitis C 
involves taking only one pill. 
OnePill 1=True 
2=False 
3=Unsure 
How likely are you to do each of the following?  
Q24 Go to a Hepatitis C 
screening at a local hospital. 
Hosp 1=Not at all likely 
2=Somewhat unlikely 
3=Neither likely nor unlikely 
4=Somewhat likely 
5=Very likely 
Q25 Go to a Hepatitis C 
screening at a local health 
clinic. 
Clinic 1=Not at all likely 
2=Somewhat unlikely 
3=Neither likely nor unlikely 
4=Somewhat likely 
5=Very likely 
Q26 Go to a Hepatitis C 
screening at my shelter. 
Shelter 1=Not at all likely 
2=Somewhat unlikely 
3=Neither likely nor unlikely 
4=Somewhat likely 
5=Very likely 
Q27 Get treatment for Hepatitis 
C if the screening revealed I 
had it. 
GetTreated 1=Not at all likely 
2=Somewhat unlikely 
3=Neither likely nor unlikely 
4=Somewhat likely 
5=Very likely 
Q28 Seek help to stop substance 
abuse (if applicable). 
SeekHelp 1=Not at all likely 
2=Somewhat unlikely 
3=Neither likely nor unlikely 
4=Somewhat likely 
5=Very likely 
Language Indicates whether the 
survey was in English or 
Spanish 
Lang 1=English 
2=Spanish 
Location Indicates the location of the 
survey 
Loc 1=Open Hearth 
2=St Vincent DePaul 
3=Youth Continuum 
4=Columbus House 
5=New London Hospitality 
House 
Quiz Score New variable that sums the 
responses for the Hepatitis 
 Score 0 = Zero answers correct 
1= 1 correct answer 
2= 2 correct answers 
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Question # Question Short Name Code Values 
C questions with 1 point for 
each correct value 
3= 3 correct answers 
4= 4 correct answers 
5 = 5 correct answers 
6= 6 correct answer 
7= 7 correct answers 
8= 8 correct answers 
9= 9 correct answers 
10 = 10 correct answers 
Quiz Grade New variable that multiples 
Score by 10 to get % 
Grade = Score * 100 
Values 0 to 100% 
EdCol New variable to separate 
out those with a college 
degree 
EdCol 1= Graduated from college 
EdSomeColl New variable created to 
separate out respondents 
with some college 
EdSomeColl 2= Some college 
EdGED New variable created to 
separate out respondents 
with high school degree as 
highest education attained 
EdGED 3 = Graduated from high 
school/GED 
EdLow New variable created to 
separate out respondents 
who completed 11th, 10th, 
9th grade or lower 
EdLow 4 = Completed 11th, 10th, 9th 
grade or lower 
Edgroup Single variable created to 
group together the 4 sub-
categories of education 
level 
Edgroup Consists of all 4 education 
groups 
Age1 New variable created to 
separate out youth aged 18 
to 30 years 
Age1 1= 18 -24 years 
Age2 New variable created to 
separate out ages 25 to 30 
years 
Age2 2 = 25 to 30 years 
Age3 New variable created to 
separate out ages 31 to 50 
years 
Age3 3 = 31 to 50 years 
Age4 New variable created to 
separate out those 51 years 
and older 
Age4 4 = 51 years and older 
Agegroup Single variable created to 
group together the 4 sub-
categories of age 
Agegroup Consists of all 4 age groups 
ScreenHospYES New variable indicating 
respondent is willing to get 
screened at a hospital.  
ScreenHospYES 1= Yes 
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Question # Question Short Name Code Values 
Based on combining values 
4 and 5. 
ScreenHospNO New variable indicating 
respondent is not willing to 
get screened at a hospital.  
Based on combining values 
1 and 2. 
ScreenHospNO 2 =No 
ScreenClinicYES New variable indicating 
respondent is willing to get 
screened at a clinic.  Based 
on combining values 4 and 
5. 
ScreenClinicYES 1= Yes 
ScreenClinicNO New variable indicating 
respondent is not willing to 
get screened at a clinic.  
Based on combining values 
1 and 2. 
ScreenClinicNO 2 =No 
ScreenShelterYES New variable indicating 
respondent is willing to get 
screened at a shelter.  
Based on combining values 
4 and 5. 
ScreenShelterYES 1= Yes 
ScreenShelterNO New variable indicating 
respondent is not willing to 
get screened at a shelter.  
Based on combining values 
1 and 2. 
ScreenShelterNO 2 =No 
Willingness New variable to group the 
willingness of respondents 
to get screened.  Values 4 
and 5 grouped, and values 1 
and 2 grouped.  Likert scale 
value 3 not used as it was a 
neutral response. 
Willingness 1= Willing to get screened 
2= Not willing to get screened 
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